To find out more about BJCP's sister journal, British Journal of Pharmacology (BJP), click here

BJCP's latest Impact Factor is now 3.128
Thomson Reuters Science Citation Index 2008
59/216 (Pharmacology & Pharmacy)

________________________________________________________
BJCP cancer drug research articles
Free access to some of the top recent cancer papers from BJCP. 
_______________________________________________________

Effects of ketoconazole and carbamazepine on lapatinib pharmacokinetics in healthy subjects.
Deborah A. Smith, Kevin M. Koch, et al.

Polymorphisms of drug-metabolizing enzymes (GST, CYP2B6 and CYP3A) affect the pharmacokinetics of thiotepa and tepa.
Corine Ekhart, Valerie D. Doodeman, et al.

Population pharmacokinetic and pharmacogenetic analysis of 6-mercaptopurine in paediatric patients with acute lymphoblastic leukaemia.
Ahmed F. Hawwa, Paul S. Collier, et al.

Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprine.
Ahmed F. Hawwa, Jeff S. Millership, et al.

Population pharmacokinetic and pharmacodynamic analysis to support treatment optimization of combination chemotherapy with indisulam and carboplatin.
Anthe S. Zandvliet, Jan H. M. Schellens, et al.

Nail and periungual toxicity following capecitabine therapy.
Mario Vaccaro, Olga Barbuzza, et al.

Candidate mechanisms for capecitabine-related hand–foot syndrome.
Gérard Milano, Marie-Christine Etienne-Grimaldi, et al.

Variability in the pharmacokinetics of intravenous busulphan given as a single daily dose to paediatric blood or marrow transplant recipients.
Christa E. Nath, John W. Earl, et al.

The clinical pharmacology of therapeutic monoclonal antibodies in the treatment of malignancy; have the magic bullets arrived?
Barrett W. Newsome, Marc S. Ernstoff

A well-tolerated 5-FU-based treatment subsequent to severe capecitabine-induced toxicity in a DPD-deficient patient.
Hélène Blasco, Michéle Boisdron-Celle, et al.

Effects of imatinib (Glivec) on the pharmacokinetics of metoprolol, a CYP2D6 substrate, in Chinese patients with chronic myelogenous leukaemia.
Yanfeng Wang, Li Zhou, Catherine Dutreix, et al.

Reversible posterior leukoencephalopathy syndrome associated with bevacizumab/doxorubicin regimen.
Franck Bürki, Kattalin Badie, et al.

Population pharmacokinetics and exploratory pharmacodynamics of ifosfamide according to continuous or short infusion schedules: an n = 1 randomized study.
Etienne G. C. Brain, Kevan Rezai, et al.

Population pharmacokinetics of gemcitabine and its metabolite in patients with cancer: effect of oxaliplatin and infusion rate.
Xuemin Jiang, Peter Galettis, et al.

Serious haematological toxicity of cyclophosphamide in relation to CYP2B6, GSTA1 and GSTP1 polymorphisms.
Agnès Tran, François Bournerias, et al. 

________________________________________________________
BJCP content relevant for prescribing and medicines management
Free access to some of the latest BJCP papers relevant to prescribing and medicines management.
_______________________________________________________

Prescribing in pregnancy and lactation.
E. J. Begg

Assessing general practitioners' prescribing behaviour in elderly patients with concealed renal failure.
Annie Pierre Jonville-Béra, Lucie Paroux, Elisabeth Autret-Leca

Candidate mechanisms for capecitabine-related hand–foot syndrome.
Gérard Milano, et al

Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials.
Liam Smeeth, Ian Douglas, Andrew J. Hall, Richard Hubbard, Stephen Evans

Suggestions for effective contraception in isotretinoin therapy.
Antonios I. Kanelleas, Steve Thornton, John Berth-Jones

________________________________________________________
BJCP content relevant for industry
Free access to some of the latest BJCP papers relevant to industry.
_______________________________________________________

Drug regulation & therapeutic efficacy.
J. M. Ritter

Thrombolysis or nothing for acute myocardial infarction? It's all the same!
Vittorio Bertele, Laura Angelici, Simona Barlera, Silvio Garattini

The clinical pharmacology of therapeutic monoclonal antibodies in the treatment of malignancy; have the magic bullets arrived?
Barrett W. Newsome, Marc S. Ernstoff

Candidate mechanisms for capecitabine-related hand–foot syndrome.
Gérard Milano, et al

A new formulation of tolevamer, a novel nonantibiotic polymer, is safe and well-tolerated in healthy volunteers: a randomized phase I trial.
Jennifer Peppe, Andrew Porzio, David M. Davidson

Variability in the quality of overdose advice in Summary of Product Characteristics (SPC) documents: gut decontamination recommendations for CNS drugs.
Andrew J. B. Wall, D. N. Bateman, W. S. Waring

________________________________________________________